- Home
- MNKD vs GO Comparison
MNKD vs GO Comparison
Compare MNKD & GO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNKD
- GO
- Stock Information
- Founded
- MNKD 1991
- GO 1946
- Country
- MNKD United States
- GO United States
- Employees
- MNKD N/A
- GO N/A
- Industry
- MNKD Biotechnology: Pharmaceutical Preparations
- GO Food Chains
- Sector
- MNKD Health Care
- GO Consumer Staples
- Exchange
- MNKD Nasdaq
- GO Nasdaq
- Market Cap
- MNKD 1.4B
- GO N/A
- IPO Year
- MNKD 2004
- GO 2019
- Fundamental
- Price
- MNKD $4.56
- GO $14.40
- Analyst Decision
- MNKD Buy
- GO Hold
- Analyst Count
- MNKD 6
- GO 13
- Target Price
- MNKD $8.92
- GO $16.38
- AVG Volume (30 Days)
- MNKD 1.5M
- GO 4.0M
- Earning Date
- MNKD 05-08-2025
- GO 05-06-2025
- Dividend Yield
- MNKD N/A
- GO N/A
- EPS Growth
- MNKD 215.86
- GO N/A
- EPS
- MNKD 0.10
- GO 0.17
- Revenue
- MNKD $297,595,000.00
- GO $4,460,124,000.00
- Revenue This Year
- MNKD $14.23
- GO $11.68
- Revenue Next Year
- MNKD $14.56
- GO $6.21
- P/E Ratio
- MNKD $46.04
- GO $82.46
- Revenue Growth
- MNKD 32.50
- GO 10.37
- 52 Week Low
- MNKD $4.17
- GO $10.26
- 52 Week High
- MNKD $7.63
- GO $23.25
- Technical
- Relative Strength Index (RSI)
- MNKD 38.80
- GO 41.36
- Support Level
- MNKD $4.42
- GO $14.75
- Resistance Level
- MNKD $5.05
- GO $16.97
- Average True Range (ATR)
- MNKD 0.18
- GO 0.71
- MACD
- MNKD 0.00
- GO -0.23
- Stochastic Oscillator
- MNKD 20.59
- GO 5.17
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.